Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Atul Vashist

Biographic Data

ID9065000
NAMEAtul Vashist
GIVEN NAMESAtul
FAMILY NAMEVashist
SIGNATUREVASHIST A
VERIFIEDNo
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR0
WORKS AS EDITOR4
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2024
H-INDEX0
  • XBB.1, BQ1.1 and atypical BA.4.6/XBB.1 recombinants predominate current Sars-CoV-2 Wavelets with flu-like symptoms in Cameroon

    Open Access•Joseph Fokam, Ezéchiel Ngoufack Jagni Semengue et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    As of December 2022, Cameroon had observed a slight resurgence of COVID-19, raising concerns on genomic surveillance of related-SARS-CoV-2 variants under circulation. Following a laboratory-based survey, positive SARS-CoV-2 samples detected from December-2022 through March-2023 were processed for targeted sequencing at the Chantal BIYA International Reference Centre (CIRCB) in Yaoundé-Cameroon. From all positive cases detected, 13 were successful…

  • Trends and determinants of acute respiratory infection symptoms among under-five children in Cambodia

    Open Access•Samnang Um, Daraden Vang et al.•EDITOR•ARTICLE•PLOS Global Public Health•2023

    Acute Respiratory Infections (ARIs) are the leading cause of mortality and morbidity among children under 5 years old and about 1.3 million annually worldwide. Account for 33% of deaths among children under 5 years that occurred in developing countries. In Cambodia, ARIs prevalence in children under 5 years old was 20% in 2000, and 6% in 2014. Hence, the aimed to describe the trends of ARI symptoms among children aged 0–59 months over time using …

  • Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective

    Open Access•Carly A Rodriguez, Sara Lodi et al.•EDITOR•ARTICLE•PLOS Global Public Health•2023

    Clarity about the role of delamanid in longer regimens for multidrug-resistant TB is needed after discordant Phase IIb and Phase III randomized controlled trial results. The Phase IIb trial found that the addition of delamanid to a background regimen hastened culture conversion; the results of the Phase III trial were equivocal. We evaluated the effect of adding delamanid for 24 weeks to three-drug MDR/RR-TB regimens on two- and six-month culture…

  • Associations between occupation, leprosy disability and other sociodemographic factors in an endemic area of Brazil

    Open Access•Juan Cisneros, José A Ferreira et al.•EDITOR•ARTICLE•PLOS Global Public Health•2022

    Background In Brazil, new leprosy cases with grade-2 disability (G2D) have been increasing. Physical disability has been associated with experienced stigmatization, psychological distress, and social restriction. Objectives To identify factors associated with leprosy disability in an endemic area of Brazil focusing on occupational and other sociodemographic factors. Methods Between July and December 2015, adult patients with multibacillary lepros…

No prominent works on this page.

  • Associations between occupation, leprosy disability and other sociodemographic factors in an endemic area of Brazil

    Open Access•Juan Cisneros, José A Ferreira et al.•EDITOR•ARTICLE•PLOS Global Public Health•2022

    Background In Brazil, new leprosy cases with grade-2 disability (G2D) have been increasing. Physical disability has been associated with experienced stigmatization, psychological distress, and social restriction. Objectives To identify factors associated with leprosy disability in an endemic area of Brazil focusing on occupational and other sociodemographic factors. Methods Between July and December 2015, adult patients with multibacillary lepros…

  • Trends and determinants of acute respiratory infection symptoms among under-five children in Cambodia

    Open Access•Samnang Um, Daraden Vang et al.•EDITOR•ARTICLE•PLOS Global Public Health•2023

    Acute Respiratory Infections (ARIs) are the leading cause of mortality and morbidity among children under 5 years old and about 1.3 million annually worldwide. Account for 33% of deaths among children under 5 years that occurred in developing countries. In Cambodia, ARIs prevalence in children under 5 years old was 20% in 2000, and 6% in 2014. Hence, the aimed to describe the trends of ARI symptoms among children aged 0–59 months over time using …

  • Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective

    Open Access•Carly A Rodriguez, Sara Lodi et al.•EDITOR•ARTICLE•PLOS Global Public Health•2023

    Clarity about the role of delamanid in longer regimens for multidrug-resistant TB is needed after discordant Phase IIb and Phase III randomized controlled trial results. The Phase IIb trial found that the addition of delamanid to a background regimen hastened culture conversion; the results of the Phase III trial were equivocal. We evaluated the effect of adding delamanid for 24 weeks to three-drug MDR/RR-TB regimens on two- and six-month culture…

  • XBB.1, BQ1.1 and atypical BA.4.6/XBB.1 recombinants predominate current Sars-CoV-2 Wavelets with flu-like symptoms in Cameroon

    Open Access•Joseph Fokam, Ezéchiel Ngoufack Jagni Semengue et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    As of December 2022, Cameroon had observed a slight resurgence of COVID-19, raising concerns on genomic surveillance of related-SARS-CoV-2 variants under circulation. Following a laboratory-based survey, positive SARS-CoV-2 samples detected from December-2022 through March-2023 were processed for targeted sequencing at the Chantal BIYA International Reference Centre (CIRCB) in Yaoundé-Cameroon. From all positive cases detected, 13 were successful…

Medicine (4 works) · Internal Medicine (3 works) · Demography (2 works) · Environmental health (2 works) · Logistic regression (2 works) · Population (2 works) · Antibiotics Pharmacokinetics and Efficacy (1 work) · Bedaquiline (1 work) · Biology (1 work) · Child Nutrition and Water Access (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae